Streetbeat News

Stock Prices

AIR

AAR Corp (NYSE:AIR) has signed a multi-year agreement with Ontic to distribute military products to the U.S. government. AAR already supports Ontic's facilities in the U.K. and North Carolina. The company reported Q2 FY24 sales of $545.4 million, a 16% increase year-over-year, but slightly below estimates. Adjusted EPS was 81 cents, surpassing the estimate by 1 cent. AAR shares saw a modest increase of 0.51% to $62.48.

Portfolio Pulse from Shivani Kumaresan

January 04, 2024 | 5:12 pm

EW

Evercore ISI Group analyst Vijay Kumar has downgraded Edwards Lifesciences (NYSE:EW) from Outperform to In-Line and reduced the price target from $80 to $77.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 5:11 pm

BLCO

Evercore ISI Group analyst Vijay Kumar downgraded Bausch & Lomb (NYSE:BLCO) from Outperform to In-Line and reduced the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 5:08 pm

ZBH

Evercore ISI Group analyst Vijay Kumar downgraded Zimmer Biomet Holdings (NYSE:ZBH) from Outperform to In-Line and reduced the price target from $135 to $125.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 5:06 pm

SNOW

Monness, Crespi, Hardt analyst Brian White downgraded Snowflake (NYSE:SNOW) from Neutral to Sell and set a price target of $160.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 5:02 pm

PM

Philip Morris Intl (NYSE:PM) has seen significant options trading activity, with a bearish sentiment from high-rolling investors. Benzinga's options scanner detected 8 trades, with 37% bullish and 62% bearish sentiment. The trades suggest a target price range of $90 to $100 over the next three months. The company, known for its tobacco products, has diversified with acquisitions of Swedish Match and Vectura. PM's stock is currently at $95.42, with potential overbought conditions and earnings expected in 35 days.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:01 pm

RIVN

Rivian Automotive (NASDAQ:RIVN) has received mixed evaluations from 8 analysts in the past three months, with an average 12-month price target of $24.62, down from the previous $27.50. Recent actions include lowered price targets by Goldman Sachs, Cantor Fitzgerald, Wells Fargo, and Wedbush, while Stifel, Cantor Fitzgerald, Needham, and UBS have given positive ratings. Rivian's financials show strong revenue growth but a high net margin loss, below-average ROE and ROA, and a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm

MLAB

Evercore ISI Group has upgraded Mesa Laboratories (NASDAQ:MLAB) from an unspecified rating to Outperform, raising the price target from $100.00 to $125.00. This represents a potential increase of 28.56% from the current share price of $97.23. Mesa Laboratories operates in life sciences tools and critical quality control products across four divisions. Analyst ratings are provided by financial analysts and are used by investors to help guide stock decisions.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm

ACLX

Needham has reaffirmed its Buy rating on Arcellx (NASDAQ:ACLX) and increased its price target from $65.00 to $71.00, implying a potential upside of 29.78% from the current share price of $54.71. Arcellx is a clinical-stage biotech company focused on developing cell therapies for cancer and other diseases.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm

GES

Jefferies has downgraded Guess (NYSE:GES) from a previous rating to Hold, adjusting the price target from $25.00 to $24.00. Guess shares have fallen 4.35% in the last 24 hours to $22.23. The new price target suggests a potential upside of 7.96% from the current price. Guess operates in various segments, with Europe being the most revenue-generating. Analyst ratings, such as this one from Jefferies, are periodic evaluations of stocks that can influence investor decisions.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm